Literature DB >> 23254468

Evaluating incremental values from new predictors with net reclassification improvement in survival analysis.

Yingye Zheng1, Layla Parast, Tianxi Cai, Marshall Brown.   

Abstract

Developing individualized prediction rules for disease risk and prognosis has played a key role in modern medicine. When new genomic or biological markers become available to assist in risk prediction, it is essential to assess the improvement in clinical usefulness of the new markers over existing routine variables. Net reclassification improvement (NRI) has been proposed to assess improvement in risk reclassification in the context of comparing two risk models and the concept has been quickly adopted in medical journals (Pencina et al., Stat Med 27:157-172, 2008). We propose both nonparametric and semiparametric procedures for calculating NRI as a function of a future prediction time [Formula: see text] with a censored failure time outcome. The proposed methods accommodate covariate-dependent censoring, therefore providing more robust and sometimes more efficient procedures compared with the existing nonparametric-based estimators (Pencina et al., Stat Med 30:11-21, 2011; Uno et al., Comparing risk scoring systems beyond the roc paradigm in survival analysis, 2009). Simulation results indicate that the proposed procedures perform well in finite samples. We illustrate these procedures by evaluating a new risk model for predicting the onset of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23254468      PMCID: PMC3686882          DOI: 10.1007/s10985-012-9239-z

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  15 in total

Review 1.  Cardiovascular risk prediction: basic concepts, current status, and future directions.

Authors:  Donald M Lloyd-Jones
Journal:  Circulation       Date:  2010-04-20       Impact factor: 29.690

Review 2.  The Framingham Risk Score: an appraisal of its benefits and limitations.

Authors:  Brian A Hemann; William F Bimson; Allen J Taylor
Journal:  Am Heart Hosp J       Date:  2007

3.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

4.  The effect of including C-reactive protein in cardiovascular risk prediction models for women.

Authors:  Nancy R Cook; Julie E Buring; Paul M Ridker
Journal:  Ann Intern Med       Date:  2006-07-04       Impact factor: 25.391

5.  Measures to summarize and compare the predictive capacity of markers.

Authors:  Wen Gu; Margaret Pepe
Journal:  Int J Biostat       Date:  2009-10-01       Impact factor: 0.968

6.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373

7.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

Review 8.  Overview of risk prediction models in cardiovascular disease research.

Authors:  Jisheng Cui
Journal:  Ann Epidemiol       Date:  2009-07-22       Impact factor: 3.797

9.  Time-dependent Predictive Values of Prognostic Biomarkers with Failure Time Outcome.

Authors:  Yingye Zheng; Tianxi Cai; Margaret S Pepe; Wayne C Levy
Journal:  J Am Stat Assoc       Date:  2008       Impact factor: 5.033

10.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

View more
  7 in total

1.  Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.

Authors:  C M Parrinello; K Matsushita; M Woodward; L E Wagenknecht; J Coresh; E Selvin
Journal:  Diabetes Obes Metab       Date:  2016-06-14       Impact factor: 6.577

2.  Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study.

Authors:  Karthik K Tennankore; Lakshman Gunaratnam; Rita S Suri; Seychelle Yohanna; Michael Walsh; Navdeep Tangri; Bhanu Prasad; Nessa Gogan; Kenneth Rockwood; Steve Doucette; Laura Sills; Bryce Kiberd; Tammy Keough-Ryan; Kenneth West; Amanda Vinson
Journal:  Can J Kidney Health Dis       Date:  2020-09-10

3.  Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study.

Authors:  Haibin Li; Yingting Zuo; Frank Qian; Shuohua Chen; Xue Tian; Penglian Wang; Xia Li; Xiuhua Guo; Shouling Wu; Anxin Wang
Journal:  Cardiovasc Diabetol       Date:  2022-06-10       Impact factor: 8.949

4.  Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes.

Authors:  Zheng Wang; Yu Cheng; Eric C Seaberg; James T Becker
Journal:  Biostatistics       Date:  2020-02-21       Impact factor: 5.279

5.  Added predictive value of omics data: specific issues related to validation illustrated by two case studies.

Authors:  Riccardo De Bin; Tobias Herold; Anne-Laure Boulesteix
Journal:  BMC Med Res Methodol       Date:  2014-10-28       Impact factor: 4.615

6.  Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.

Authors:  Xiao Xu; Di Lu; Qi Ling; Xuyong Wei; Jian Wu; Lin Zhou; Sheng Yan; Liming Wu; Lei Geng; Qinghong Ke; Feng Gao; Zhenhua Tu; Weilin Wang; Min Zhang; Yan Shen; Haiyang Xie; Wenshi Jiang; Haibo Wang; Shusen Zheng
Journal:  Gut       Date:  2015-03-24       Impact factor: 23.059

7.  Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.

Authors:  Katie Harris; Megumi Oshima; Naveed Sattar; Peter Würtz; Min Jun; Paul Welsh; Pavel Hamet; Stephen Harrap; Neil Poulter; John Chalmers; Mark Woodward
Journal:  Diabetologia       Date:  2020-05-08       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.